Participant perspectives on a phase I/II ocular gene therapy trial (NCT02077361)-Reference-Cited by-同舟云学术

Participant perspectives on a phase I/II ocular gene therapy trial (NCT02077361)

Published:2019-05-04 Issue:3 Volume:40 Page:276-281
ISSN:1381-6810
Container-title:Ophthalmic Genetics
language:en
Short-container-title:Ophthalmic Genetics

Author:

Brooks Stephanie P.¹^ORCID,Benjaminy Shelly²,Bubela Tania³

Affiliation:

1. Faculty of Medicine and Dentistry, Edmonton, Alberta, Canada

2. Shirley Ryan AbilityLab, Chicago, Illinois, USA

3. Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada

Funder

Alberta Innovates - Health Solutions

Canadian Institutes of Health Research

Foundation Fighting Blindness

Publisher

Informa UK Limited

Subject

Genetics (clinical),Ophthalmology,Pediatrics, Perinatology and Child Health

Link

https://tandfonline.com/doi/pdf/10.1080/13816810.2019.1630843

Reference30 articles.

1. FDA. c. 2017: FDA News Release - FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss. www.fda.gov [Internet]. Maryland, United States; 2017 Dec 19 [accessed 2018 Mar 22]; [1 screen]. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm589467.htm.

2. Gene Transfer and the Ethics of First-in-Human Research

3. Communicating the Promise for Ocular Gene Therapies: Challenges and Recommendations

4. Supporting positive experiences and sustained participation in clinical trials: looking beyond information provision

5. Patient–physician communication concerning participation in cancer chemotherapy trials

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Somatic Gene Therapy: Ethics and Access;Annual Review of Genomics and Human Genetics;2024-08-27

2. Safety and Efficacy of Adeno-Associated Viral Gene Therapy in Patients With Retinal Degeneration: A Systematic Review and Meta-Analysis;Translational Vision Science & Technology;2023-11-20

3. Survey of perspectives of people with inherited retinal diseases on ocular gene therapy in Australia;Gene Therapy;2022-10-02

4. Measurement Properties of the Attitudes to Gene Therapy for the Eye (AGT-Eye) Instrument for People With Inherited Retinal Diseases;Translational Vision Science & Technology;2022-02-08

5. GEOGRAPHIC ACCESS DISPARITIES TO CLINICAL TRIALS IN RETINOPATHY OF PREMATURITY IN THE UNITED STATES;Retina;2021-11